IS7415A - N-{'(2S)-4-(3,4-díflúrbensýl)morfólín-2ýl!metýl}-2-{3-'(metýlsúlfónýl)amínó!fenýl} asetamíð sem CCR3 mótlyf fyrir meðhöndlun bólgusjúkdóma - Google Patents

N-{'(2S)-4-(3,4-díflúrbensýl)morfólín-2ýl!metýl}-2-{3-'(metýlsúlfónýl)amínó!fenýl} asetamíð sem CCR3 mótlyf fyrir meðhöndlun bólgusjúkdóma

Info

Publication number
IS7415A
IS7415A IS7415A IS7415A IS7415A IS 7415 A IS7415 A IS 7415A IS 7415 A IS7415 A IS 7415A IS 7415 A IS7415 A IS 7415A IS 7415 A IS7415 A IS 7415A
Authority
IS
Iceland
Prior art keywords
difluorobenzyl
methylsulfonyl
ylmethyl
acetamide
morpholine
Prior art date
Application number
IS7415A
Other languages
English (en)
Inventor
Ann Ancliff Rachel
Mary Cook Caroline
David Eldred Colin
Martin Gore Paul
Andrew Harrison Lee
Alistair Hayes Martin
Teanby Hodgson Simon
Bruce Judd Duncan
Elaine Keeling Suzanne
Qing Lewell Xiao
Mills Gail
Michael Robertson Graeme
Swanson Stephen
John Walker Andrew
Wilkinsson Mark
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS7415A publication Critical patent/IS7415A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IS7415A 2002-03-28 2004-08-19 N-{'(2S)-4-(3,4-díflúrbensýl)morfólín-2ýl!metýl}-2-{3-'(metýlsúlfónýl)amínó!fenýl} asetamíð sem CCR3 mótlyf fyrir meðhöndlun bólgusjúkdóma IS7415A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0207449.0A GB0207449D0 (en) 2002-03-28 2002-03-28 Novel compounds
PCT/EP2003/003339 WO2003082291A1 (en) 2002-03-28 2003-03-27 N-{´ (2s) -4- (3, 4-difluorobenzyl) morpholin-2yl!methyl} -2-{3-' (methylsulphonyl) amino! phenyl}acetamide as ccr3 antagonist for the treatment of inflammatory conditions

Publications (1)

Publication Number Publication Date
IS7415A true IS7415A (is) 2004-08-19

Family

ID=9933998

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7415A IS7415A (is) 2002-03-28 2004-08-19 N-{'(2S)-4-(3,4-díflúrbensýl)morfólín-2ýl!metýl}-2-{3-'(metýlsúlfónýl)amínó!fenýl} asetamíð sem CCR3 mótlyf fyrir meðhöndlun bólgusjúkdóma

Country Status (22)

Country Link
US (1) US20060058299A1 (is)
EP (1) EP1487453B1 (is)
JP (1) JP4490110B2 (is)
KR (1) KR20040095347A (is)
CN (1) CN1642553A (is)
AR (1) AR039177A1 (is)
AT (1) ATE454892T1 (is)
AU (1) AU2003216905A1 (is)
BR (1) BR0308719A (is)
CA (1) CA2479910A1 (is)
DE (1) DE60330952D1 (is)
ES (1) ES2339436T3 (is)
GB (1) GB0207449D0 (is)
IL (1) IL163648A0 (is)
IS (1) IS7415A (is)
MX (1) MXPA04009458A (is)
NO (1) NO20044098L (is)
PL (1) PL372930A1 (is)
RU (1) RU2004126145A (is)
TW (1) TW200400823A (is)
WO (1) WO2003082291A1 (is)
ZA (1) ZA200406990B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919356B2 (en) 2002-09-26 2005-07-19 Bristol Myers Squibb Company N-substituted heterocyclic amines as modulators of chemokine receptor activity
EP1919884A1 (en) * 2005-07-21 2008-05-14 AstraZeneca AB N-benzyl-morpholine derivatives as modulators of the chemokine receptor
HUP0500877A2 (en) * 2005-09-22 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates
AU2006293635A1 (en) * 2005-09-22 2007-03-29 Sanofi-Aventis Amino-alkyl-amide derivatives as CCR3 receptor liquids
HUP0500886A2 (en) * 2005-09-23 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use
HUP0800478A2 (en) * 2008-07-31 2010-03-01 Sanofi Aventis Substituted pyrrolidinyl-[1,3]thiazolo[4,5-b]pyridin derivatives as ccr3 receptor ligands
JP2015500221A (ja) * 2011-12-01 2015-01-05 グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ 眼疾患の治療および予防方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS562929A (en) * 1979-06-21 1981-01-13 Sumitomo Chem Co Ltd Preparation of optically active cyclopentenolone
US4870074A (en) * 1986-04-30 1989-09-26 Dainippon Pharmaceutical Co., Ltd. Substituted benzamide derivatives, for enhancing gastrointestinal motility
JPH01117882A (ja) * 1987-10-30 1989-05-10 Dainippon Pharmaceut Co Ltd 複素環式カルボン酸アミド誘導体
JPH03291274A (ja) * 1990-04-09 1991-12-20 Yoshitomi Pharmaceut Ind Ltd アミノアルキルモルホリン誘導体の製造法
JPH04270272A (ja) * 1991-02-25 1992-09-25 Yoshitomi Pharmaceut Ind Ltd アミノアルキルモルホリン誘導体の製造法
TW223629B (is) * 1992-03-06 1994-05-11 Hoffmann La Roche
US5219856A (en) * 1992-04-06 1993-06-15 E. I. Du Pont De Nemours And Company Angiotensin-II receptor blocking, heterocycle substituted imidazoles
US6031097A (en) * 1997-10-27 2000-02-29 Neurogen Corporation 1-(N-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands
AU2056800A (en) * 1998-12-18 2000-07-03 Du Pont Pharmaceuticals Company Heterocyclic piperidines as modulators of chemokine receptor activity
PL354481A1 (en) * 1999-09-14 2004-01-26 Aventis Pharmaceuticals, Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4
NZ525055A (en) * 2000-09-29 2004-09-24 Glaxo Group Ltd Compounds useful in the treatment of inflammatory diseases
EP1324990B1 (en) * 2000-09-29 2014-10-29 Glaxo Group Limited Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Also Published As

Publication number Publication date
CN1642553A (zh) 2005-07-20
ES2339436T3 (es) 2010-05-20
JP2005525390A (ja) 2005-08-25
DE60330952D1 (de) 2010-03-04
EP1487453A1 (en) 2004-12-22
PL372930A1 (en) 2005-08-08
NO20044098L (no) 2004-10-04
KR20040095347A (ko) 2004-11-12
JP4490110B2 (ja) 2010-06-23
EP1487453B1 (en) 2010-01-13
ATE454892T1 (de) 2010-01-15
ZA200406990B (en) 2005-11-08
US20060058299A1 (en) 2006-03-16
TW200400823A (en) 2004-01-16
BR0308719A (pt) 2005-01-04
AU2003216905A1 (en) 2003-10-13
GB0207449D0 (en) 2002-05-08
RU2004126145A (ru) 2005-06-27
WO2003082291A1 (en) 2003-10-09
CA2479910A1 (en) 2003-10-09
IL163648A0 (en) 2005-12-18
AR039177A1 (es) 2005-02-09
MXPA04009458A (es) 2005-07-27

Similar Documents

Publication Publication Date Title
CY2009013I2 (el) Νεα χρηση μιας ενωσης πεπτιδικης κατηγοριας για τη θεραπεια του μη νευροπαθους φλεγμονωδους πονου
AU2003285091A8 (en) Interferon antagonists useful for the treatment of interferon related diseases
ATE361279T1 (de) N-[phenyl(piperidin-2-yl)methyl]benzamidderivat , verfahren zu ihrer herstellung und ihre therapeutische anwendung
DK1575597T3 (da) Anvendelse af rimexolon til behandling af öjentörhed
DK1944322T3 (da) Behandling af TNFalfa-relaterede sygdomme
CY2014004I2 (el) Χρηση (ζ)-2-κυανο-3-υδροξυ-βουτ-2-ενοικου οξεος-(4΄-τριφθορομεθυλοφαινυλο)-αμιδης για τη θεραπεια της πολλαπλης σκληρωσης
ATE381263T1 (de) Fungizide zusammensetzungen, die n-(alpha-cyano-2-thenyl)-4-ethyl-2-ethylamino-5 thiazolcarboxamide enthalten
IS7415A (is) N-{'(2S)-4-(3,4-díflúrbensýl)morfólín-2ýl!metýl}-2-{3-'(metýlsúlfónýl)amínó!fenýl} asetamíð sem CCR3 mótlyf fyrir meðhöndlun bólgusjúkdóma
ITMI20032172A1 (it) Procedimento atto alla correzione dell'arricchimento di
DE60236534D1 (de) Verbesserte herbizidzusammensetzung
NO20025964L (no) Ny interferon for behandling av multippel sklerose
DE60223828D1 (de) Spermizide
ITBO20020103A1 (it) Macchina ginnica con controllo delle prestazioni dell'utilizzatore
UA6407S (uk) Набір печива «доміношки»
UA6408S (uk) Набір печива «турнір»
NL300932I2 (nl) ocrelizumab
ITRM20030573A1 (it) Dispositivo per la regolazione dell'orientamento di un
RU2002103167A (ru) Кардиопротекторное средство
SE0201766D0 (sv) Golftillbehör "Greenlagare"
ES1052456Y (es) "tacos silenciadores autoadhesibles"
ITRE20030040A0 (it) Bandella per la realizzazione di rulli sfregatori"
ITLU20020007U1 (it) "calendario-libro"
ITMI20022678A1 (it) Negativoscopio con mezzi di mascheratura dell'area di
UA7029S (uk) Комплект жіночого одягу
UA6536S (uk) Комплект жіночого одягу